Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia

PHASE3CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

January 31, 2018

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Z-213

The total iron dosage is calculated based on hemoglobin value and the patients' weight, IV on day 1, 8 and 15 (if needed)

DRUG

Saccharated Ferric Oxide

The total iron dosage is calculated based on hemoglobin value and the patients' weight, IV two or three times per week

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY